Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             87 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A boy with uncertain diagnosis of cystic fibrosis becoming more certain Pisesky, Andrea
2014
47 15 p. 134-
1 p.
artikel
2 A guide to understanding the steroid pathway: New insights and diagnostic implications Greaves, Ronda F.
2014
47 15 p. 5-15
11 p.
artikel
3 Alternations of galectin levels after renal transplantation Tan, Ruoyun
2014
47 15 p. 83-88
6 p.
artikel
4 Alzheimer and platelets: Low-density platelet populations reveal increased serotonin content in Alzheimer type dementia Milovanovic, Micha
2014
47 15 p. 51-53
3 p.
artikel
5 Amoxicillin-associated interference in an HPLC–EC assay for urinary fractionated metanephrines: Potential pitfall in pheochromocytoma biochemical diagnosis Barco, Sebastiano
2014
47 15 p. 119-121
3 p.
artikel
6 A newborn with persistent mild elevations of succinylacetone in bloodspot, plasma and urine, without identified mutations in the FAH gene Waters, Paula J.
2014
47 15 p. 144-
1 p.
artikel
7 Application of Plackett–Burman and Doehlert designs for optimization of selenium analysis in plasma with electrothermal atomic absorption spectrometry El Ati-Hellal, Myriam
2014
47 15 p. 95-100
6 p.
artikel
8 A REDCap database to support longitudinal follow-up of pediatric patients with inborn errors of metabolism Hernandez, Monica
2014
47 15 p. 138-
1 p.
artikel
9 A sensitive and specific UPLC–MS/MS multiplex analysis of urinary glycosaminoglycans for an efficient diagnosis of patients with mucopolysaccharidosis types I, II, III, IV, and VI Lavoie, Pamela
2014
47 15 p. 141-
1 p.
artikel
10 Assessment of barriers to drug adherence in the treatment of urea cycle disorders in North America Shchelochkov, Oleg A.
2014
47 15 p. 153-
1 p.
artikel
11 Biological variation of the osmolality and the osmolal gap Wu, Alan H.B.
2014
47 15 p. 130-131
2 p.
artikel
12 Biotinidase deficiency: Spectrum of molecular, enzymatic and clinical information—A pilot project Prasad, Chitra
2014
47 15 p. 148-
1 p.
artikel
13 Blood distribution of bortezomib and its kinetics in multiple myeloma patients Osawa, Takashi
2014
47 15 p. 54-59
6 p.
artikel
14 Blood phenylalanine concentrations and dietary phenylalanine tolerance in patients with PKU in response to treatment with sapropterin hydrochloride: A multidimensional approach to determine clinically meaningful outcomes Stockler-Ipsiroglu, Sylvia
2014
47 15 p. 138-
1 p.
artikel
15 Building a pan-Canadian practice-based research network for inherited metabolic diseases: The first two years of the Canadian Inherited Metabolic Diseases Research Network (CIMDRN) Potter, Beth K.
2014
47 15 p. 137-138
2 p.
artikel
16 Continuous gene deletion syndrome in two families involving OTC, RPGR and TSPAN7 genes, presenting as ornithine transcarbamylase deficiency Jain-Ghai, Shailly
2014
47 15 p. 136-137
2 p.
artikel
17 Deproteination of whole blood for LC–MS/MS using paramagnetic micro-particles Van den Bossche, Dorien
2014
47 15 p. 112-115
4 p.
artikel
18 Describing the utility of the newborn screening Molecular Assessment Program (MAP) in US Public Health Laboratories Degeberg, Ruhiyyih A.
2014
47 15 p. 136-
1 p.
artikel
19 Development and validation of reversed phase chromatography method for acylcarnitine analysis and its application to second tier newborn screening for inborn organic acid disorders Pany, Faisal Adam
2014
47 15 p. 139-140
2 p.
artikel
20 Development of a rapid clinical TPMT genotyping assay Burchard, Paul R.
2014
47 15 p. 126-129
4 p.
artikel
21 Does registration of the medical science workforce deliver a competent profession? Badrick, Tony
2014
47 15 p. 1-4
4 p.
artikel
22 Editorial Board 2014
47 15 p. IFC-
1 p.
artikel
23 Efficacy of a MCT supplementation with galactose restricted diet in an infant with citrin deficiency and a novel variant in the SLC25A13 gene Al Mandhari, Hilal K.
2014
47 15 p. 139-
1 p.
artikel
24 Establishment of hormone reference intervals for infants born <30weeks' gestation Greaves, Ronda F.
2014
47 15 p. 101-108
8 p.
artikel
25 Examining the genotype–phenotype relationship for patients with very-long-chain acyl CoA dehydrogenase deficiency Tingley, Kylie
2014
47 15 p. 137-
1 p.
artikel
26 Exosomal transfer from human renal proximal tubule cells to distal tubule and collecting duct cells Gildea, John J.
2014
47 15 p. 89-94
6 p.
artikel
27 Expansion of the known phenotype for mitochondrial translation elongation factor G1 (EGF1) due to GFM1 mutations Nasr, Enas N.
2014
47 15 p. 144-
1 p.
artikel
28 Fast ibuprofen, ketoprofen and naproxen simultaneous determination in human serum for clinical toxicology by GC–FID Hložek, Tomáš
2014
47 15 p. 109-111
3 p.
artikel
29 Five-year review of newborn screening for congenital hypothyroidism (CH) in Alberta Bamforth, Fiona
2014
47 15 p. 148-149
2 p.
artikel
30 Glucose 6 phosphate dehydrogenase deficiency: An urgent need for newborn screening in India Kapoor, Seema
2014
47 15 p. 146-
1 p.
artikel
31 GM2 gangliosidoses: Developing methods for screening and monitoring the disease Lehotay, Denis C.
2014
47 15 p. 142-
1 p.
artikel
32 Homocysteine analysis in dried blood spots by LC–MS/MS as a second tier test for homocystinuria Chambers, Amy E.
2014
47 15 p. 140-
1 p.
artikel
33 How does learning false positive results through newborn screening for cystic fibrosis influence cascade testing and family planning? Bombard, Yvonne
2014
47 15 p. 134-135
2 p.
artikel
34 Implementing newborn screening policy through a province wide communication campaign Earl, Teresa L.
2014
47 15 p. 133-
1 p.
artikel
35 Incorporating the measurement of EDTA in dried blood spots (DBS) by tandem mass spectrometry in routine newborn screening Fisher, Lawrence J.
2014
47 15 p. 144-
1 p.
artikel
36 In the loop: Primary care providers' role in newborn screening for cystic fibrosis Hayeems, Robin Z.
2014
47 15 p. 147-148
2 p.
artikel
37 Is confirmatory genetic testing of all CF screen positives justified? Chauhan, Nita
2014
47 15 p. 135-
1 p.
artikel
38 Is it time to consider LC–MS/MS measurement of mucopolysaccharides as the first line screening test for Sanfilippo disease? Vallance, Hilary
2014
47 15 p. 141-142
2 p.
artikel
39 Is plasma and urine neutrophil gelatinase-associated lipocalin (NGAL) determination in donors and recipients predictive of renal function after kidney transplantation? Buemi, Antoine
2014
47 15 p. 68-72
5 p.
artikel
40 Liver cell transplantation as a “bridge” therapy for urea cycle disorders: The Calgary experience Khan, Aneal
2014
47 15 p. 150-151
2 p.
artikel
41 Making sense of diagnostic uncertainty after newborn screening for cystic fibrosis Barg, Carolyn J.
2014
47 15 p. 135-
1 p.
artikel
42 Mass or high-risk screening of creatine synthesis and transport disorders, triple H syndrome and OTC deficiency using a multiplex tandem mass spectrometry methodology Auray-Blais, Christiane
2014
47 15 p. 146-147
2 p.
artikel
43 Mass spectrometric determination of purine metabolites in DBS: A novel second tier approach to detecting adenosine deaminase deficiency in the screening for severe combined immunodeficiency McIntosh, Nathan A.
2014
47 15 p. 150-
1 p.
artikel
44 Mesenteric lymphadenopathy and protein-losing enteropathy in Gaucher disease type 3 despite combined enzyme replacement & substrate reduction therapy Mhanni, A.
2014
47 15 p. 139-
1 p.
artikel
45 Metabolic clinic atlas: Organization of care for pediatric metabolic patients in Canada Kronick, Jonathan B.
2014
47 15 p. 152-
1 p.
artikel
46 Metabolomics for discovery of biomarkers for cystic fibrosis: Towards MS-based primary screening methods with improved positive predictive value DiBattista, Alicia
2014
47 15 p. 143-
1 p.
artikel
47 Metabolomics for improved patient stratification in cystic fibrosis: Characterization of the sweat metabolome Macedo, Adriana N.
2014
47 15 p. 143-
1 p.
artikel
48 Methylmalonic aciduria: A common incidental finding in infants undergoing metabolic investigation Rakic, Bojana
2014
47 15 p. 145-
1 p.
artikel
49 Molecular, biochemical and clinical heterogeneity in very-long-chain acyl-CoA dehydrogenase deficiency in the Canadian Maritime Provinces Gillis, Jane
2014
47 15 p. 147-
1 p.
artikel
50 Multiplexed separations for rapid confirmatory testing of screen-positive inborn errors of metabolism DiBattista, Alicia
2014
47 15 p. 150-
1 p.
artikel
51 Newborn screening for hemoglobinopathies using HPLC and capillary electrophoresis: Initial findings from the Quebec Newborn Blood Screening Program Berthier, Marie-Thérèse
2014
47 15 p. 132-
1 p.
artikel
52 Newborn Screening Molecular Assessment Program for quality improvement Greene, Christopher N.
2014
47 15 p. 136-
1 p.
artikel
53 Newborn screening policy in Australia Maxwell, Susannah J.
2014
47 15 p. 146-
1 p.
artikel
54 Novel methylated Gb3 isoform biomarker analysis using UPLC–MS/MS for Fabry disease patients Abaoui, Mona
2014
47 15 p. 140-141
2 p.
artikel
55 Optimizing protein precipitation efficiency for assessing the contribution of low molecular weight compounds to serum antioxidant capacity Crowe, Kristi M.
2014
47 15 p. 116-118
3 p.
artikel
56 Outcome of infants with elevated C5OH acylcarnitine: Seven years of newborn screening follow-up at the Calgary Metabolic Clinic Lazier, Joanna
2014
47 15 p. 148-
1 p.
artikel
57 Outcomes in 48 individuals with guanidinoacetatemethyltransferase (GAMT) deficiency and establishment of a Canadian longitudinal database Stockler-Ipsiroglua, Sylvia
2014
47 15 p. 151-
1 p.
artikel
58 Parent attitudes to newborn screening consent practices Nicholls, Stuart G.
2014
47 15 p. 133-134
2 p.
artikel
59 Patient- and family-oriented outcomes for inborn errors of metabolism: A scoping review Khangura, Sara D.
2014
47 15 p. 149-
1 p.
artikel
60 Patient- and family-oriented outcomes for inborn errors of metabolism: The perspective of patient advocacy and support groups Khangura, Sara D.
2014
47 15 p. 145-
1 p.
artikel
61 Profiling of glycosphingolipids for relative organ distribution in a pure strain of Fabry mice Provençal, Philippe
2014
47 15 p. 141-
1 p.
artikel
62 Psychosis: Clinical evaluation for inborn errors of metabolism Trakadis, Yannis
2014
47 15 p. 152-153
2 p.
artikel
63 Quality assurance in the laboratory testing process: Indirect estimation of the reference intervals for platelet parameters in neonates Grecu, Daniela Stefania
2014
47 15 p. 33-37
5 p.
artikel
64 Rapid confirmatory testing of thyroxine status by multi-segment capillary electrophoresis-mass spectrometry with chemical derivatization Shanmuganathan, Meera
2014
47 15 p. 143-
1 p.
artikel
65 Rapid second-tier testing for newborn screening and therapeutic monitoring of maple syrup urine disease Sinclair, Graham
2014
47 15 p. 149-150
2 p.
artikel
66 Redefining normal bone and mineral clinical biochemistry reference intervals for healthy infants in Canada Gallo, Sina
2014
47 15 p. 27-32
6 p.
artikel
67 Relationship between the paraoxonase 1 gene glutamine 192 to arginine polymorphism and gestational diabetes mellitus in Saudi women Al-Hakeem, Malak Mohammed
2014
47 15 p. 122-125
4 p.
artikel
68 Sapropterin is associated with improvements in assessments of executive function in Canadian patients with phenylketonuria Deschênes, Elaine
2014
47 15 p. 138-139
2 p.
artikel
69 Selenium adjuvant therapy in septic patients selected according to Carrico index Kočan, Ladislav
2014
47 15 p. 44-50
7 p.
artikel
70 Serum adhesion molecules as outcome predictors in adult severe sepsis patients requiring mechanical ventilation in the emergency department Kung, Chia-Te
2014
47 15 p. 38-43
6 p.
artikel
71 Severe combined immunodeficiency (SCID) screening in Ontario — Methodology and workflow used by Newborn Screening Ontario (NSO) Yeh, Ed
2014
47 15 p. 142-
1 p.
artikel
72 Simultaneous LC–MS/MS determination of sialic acid, pipecolic acid and piperideine-6-carboxylate in biological fluids, for diagnosis and monitoring of inherited metabolic disorders Waters, Paula J.
2014
47 15 p. 142-
1 p.
artikel
73 The development and validation of a turbulent flow-liquid chromatography–tandem mass spectrometric method for the simultaneous quantification of citalopram, sertraline, bupropion and hydroxybupropion in serum Petrides, Athena K.
2014
47 15 p. 73-79
7 p.
artikel
74 The development of a genetic newborn screening assay for permanent hearing loss using blood spots — A collaboration between Newborn Screening Ontario (NSO) and the Infant Hearing Program (IHP) Yeh, E.
2014
47 15 p. 149-
1 p.
artikel
75 The epidemiology and health service impact of medium-chain acyl-CoA dehydrogenase deficiency among affected children and those with false positive newborn screening results in Ontario Karaceper, Maria D.
2014
47 15 p. 132-133
2 p.
artikel
76 The experiences of Libyan physicians with congenital disorders and their attitudes towards newborn screening Shickh, Salma A.
2014
47 15 p. 134-
1 p.
artikel
77 The extended nationwide newborn screening program in the state of Qatar (in cooperation with the Neonatal Screening Centre in University Children Hospital Heidelberg-Germany) — 10year outcome Abdoh, Ghassan M.
2014
47 15 p. 146-
1 p.
artikel
78 The importance of challenging phenylalanine (Phe) tolerance in patients with phenylketonuria (PKU) Langley, Erica L.
2014
47 15 p. 151-152
2 p.
artikel
79 Towards a clinical trial of lentivirus-mediated gene therapy for Fabry disease: In vitro patient cell mobilization and transduction outcomes Rupar, Tony
2014
47 15 p. 151-
1 p.
artikel
80 Treatment-related signs and symptoms among patients with urea cycle disorders (UCDs) during treatment with sodium phenylbutyrate and glycerol phenylbutyrate Nagamani, Sandesh C.
2014
47 15 p. 153-
1 p.
artikel
81 Two new unrelated cases of pyrroline-5-carboxylate synthase — New founder effect? Trakadis, Y.
2014
47 15 p. 145-
1 p.
artikel
82 Unsatisfactory dried blood spot sample rates: Does audit and feedback drive quality improvement? Dougan, Shelley
2014
47 15 p. 133-
1 p.
artikel
83 UPLC-based metabonomic applications for discovering biomarkers of diseases in clinical chemistry Zhao, Ying-Yong
2014
47 15 p. 16-26
11 p.
artikel
84 UPLC MS/MS quantitation of AQC-derivatized amino acids for detection of inborn errors of metabolism Seargeant, Lorne E.
2014
47 15 p. 140-
1 p.
artikel
85 Use of synthetic urine as a matrix substitute for standard and quality control materials in the clinical assessment of iodine by inductively coupled plasma mass spectrometry Haglock-Adler, Carrie J.
2014
47 15 p. 80-82
3 p.
artikel
86 Variants in genes encoding pyrophosphate metabolizing enzymes are associated with Pseudoxanthoma elasticum Dabisch-Ruthe, Mareike
2014
47 15 p. 60-67
8 p.
artikel
87 We are the 1%: Newborn screening for cystic fibrosis and true positive cases from category C screening Tam, Karen
2014
47 15 p. 135-136
2 p.
artikel
                             87 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland